Ultrasound needle guide trial pulled before it even started
NCT ID NCT03879161
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a new ultrasound device with a needle guide for placing a needle into the femoral artery during liver cancer treatment. The goal was to see if the device made the procedure safer and more accurate. However, the trial was withdrawn before enrolling any participants, so no results are available.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Vu-Path™ percutaneous ultrasound device with needle guide
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC LIVER CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Johns Hopkins School of Medicine
Baltimore, Maryland, 21287, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could a tailored diet before surgery boost liver cancer recovery?
- Engineered immune cells take aim at childhood liver cancers
- Could squeezing a ball make port needle changes less painful?
- Dialysis dilemma: catheter or fistula for the elderly?
- New catheter coating could cut dialysis complications
- One needle to rule them all: new dialysis device aims to simplify treatment